Comparative Pharmacology
Head-to-head clinical analysis: TEVETEN HCT versus VALSARTAN HYDROCHLOROTHIAZIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TEVETEN HCT versus VALSARTAN HYDROCHLOROTHIAZIDE.
TEVETEN HCT vs VALSARTAN; HYDROCHLOROTHIAZIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
TEVETEN HCT combines eprosartan mesylate, an angiotensin II receptor antagonist, and hydrochlorothiazide, a thiazide diuretic. Eprosartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively antagonizing the AT1 receptor. Hydrochlorothiazide inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume.
Valsartan is an angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor, leading to vasodilation and reduced aldosterone secretion. Hydrochlorothiazide is a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium and water.
One tablet orally once daily, containing eprosartan 600 mg and hydrochlorothiazide 12.5 mg or 25 mg, with or without food. Maximum dose: eprosartan 600 mg/hydrochlorothiazide 25 mg per day.
80-320 mg valsartan / 12.5-25 mg hydrochlorothiazide once daily orally, titrated based on blood pressure response.
None Documented
None Documented
Eprosartan: 5-9 hours; Hydrochlorothiazide: 6-15 hours; allows once-daily dosing.
Valsartan: terminal half-life is approximately 6 hours. Hydrochlorothiazide: terminal half-life ranges from 5.6 to 14.8 hours, with an average of about 8 hours; prolonged in renal impairment.
Eprosartan: renal (70% unchanged, 10% as metabolite), biliary/fecal (20%); Hydrochlorothiazide: renal (≥95% unchanged).
Valsartan: primarily excreted unchanged in feces (70%) via biliary elimination, with renal excretion accounting for about 30% (mostly unchanged). Hydrochlorothiazide: eliminated by renal excretion, with approximately 95% of the absorbed dose excreted unchanged in urine via tubular secretion.
Category C
Category D/X
ARB + Thiazide Diuretic Combination
ARB